BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $10.9 million in its fourth quarter.

The Burlingame, California-based company said it had a loss of 28 cents per share.

The biopharmaceutical company posted revenue of $951,000 in the period.

For the year, the company reported that its loss narrowed to $21.8 million, or 55 cents per share. Revenue was reported as $42.2 million.

In the final minutes of trading on Tuesday, the company's shares hit $4.94. A year ago, they were trading at $6.01.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News